Prescription Drug Affordability Board Activity through November 15, 2024
Activities Summary
Colorado held no meeting in November. The next meeting will be December 6, 2024.
Maryland's Prescription Drug Affordability Board (PDAB) met on October 28, 2024 and the Prescription Drug Affordability Stakeholder Council (PDASC) met on November 4, 2024. Both bodies are working together to develop an Upper Payment Limit Action Plan. The PDAB staff is developing a dossier to make affordability determinations while the board is seeking guidance on the impact of the prescription drug cost relative to insurance benefit design. Staff are collecting additional data about rebates between insurance companies and manufacturers, cost and utilization data from state Medicaid and state employees, and out-of-pocket costs. The board is using the proposed new review process to conduct a cost review on six drugs.: Farxiga (dapagliflozin), Jardiance (empagliflozin), Ozempic (semaglutide), and Trulicity (dulaglutide), as well as Dupixent (dupilumab) and Skyrizi (risankizumab), which have not yet had a request for information (RFI) completed. The next PDAB meeting is November 25, 2024.
The PDAB Executive Director presented to the PDASC on the upper payment limit and policy review process and cost review study process. The following discussion covered definitions and implementation of upper payment limits. The next PDASC meeting is scheduled for December 16, 2024.
Oregon’s ’s next meeting is November 20, 2024.
A recording of Washington’s November 13, 2023 meeting is not yet publicly available.
Activity by State
The next PDAB Meeting will be held on Friday, December 6, from 10 am - 2 pm MT.
Maryland has two entities working together: the Prescription Drug Affordability Stakeholder Council (PDASC) and the Prescription Drug Affordability Board (PDAB).
PDAB Meeting October 28, 2024
The Prescription Drug Affordability Board held an Ad-Hoc meeting on October 28, 2024. Review the agenda and comments. Watch the meeting.
Opportunity for Public Comments
No oral comment.
Updates from Executive Director Andrew York:
Administrative Update Chair’s Update
The next Prescription Drug Affordability Board meeting will be held in-person November 25, 2024, at 2 PM. A December meeting may be added based on the progress made in November.
PDASC Meeting November 4, 2024
The PDASC met on November 4, 2024. Meeting materials are available here. Watch the meeting.
After calling the meeting to order and roll call, the minutes from the August 26, 2024 meeting were approved.
Next Meeting Details
The next PDASC meeting will be Monday, December 16, 2024 at 2pm EST.
The next meeting is November 20, 2024.
Washington’s PDAB met on November 13, 2024. Agenda available here. Video not yet available for review.
Standout resources and coverage
Are PDABs Pushing the Limit? Drug Pricing Complexities Collide with Implementation, Morgan Lewis, October 4, 2024
"While Oregon has started questioning the practical benefits to PDABs setting UPLs, Maryland has conversely approved a process that could lead to UPLs on high-cost prescription drugs for state health plans."
"In Maryland, drug price controls won’t help patient affordability," Kelly Schulz in Maryland Matters, October 26, 2024
"At a time when Maryland could be accelerating medical innovation to meet the world’s health challenges, our state’s policymakers are taking steps that could curb medical advancements and disrupt patient access and care."